Cero Therapeutics Holdings CERO
CERO

Cero Therapeutics Holdings (CERO) Interest Coverage Ratio (2023 - 2026)

Updated

Cero Therapeutics Holdings' Interest Coverage Ratio was -5.57 in Q2 2026.

Analysis

Cero Therapeutics Holdings (CERO) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cero Therapeutics Holdings' Interest Coverage Ratio was -21.77 through Jun 30, 2026; for FY2024, it was -700.40.

  • In earlier years, Interest Coverage Ratio was -55.48 in FY2023.
  • The Q2 2026 figure marks the highest quarterly Interest Coverage Ratio in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,142.38 Bn 1,110.97 Bn 19.71 Bn -
2 Johnson & Johnson 635.12 Bn 554.98 Bn 17.30 Bn 28.50
3 AbbVie 500.65 Bn 473.76 Bn 12.70 Bn -
4 Merck 355.26 Bn 309.64 Bn 12.21 Bn -
5 Novartis Ag 300.41 Bn 264.40 Bn 11.24 Bn 10.28
6 Astrazeneca 263.79 Bn 237.48 Bn 12.86 Bn 7.27
7 Amgen 238.16 Bn 193.56 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -42.08
9 Pfizer 170.34 Bn 116.99 Bn 10.94 Bn -
10 Cero Therapeutics Holdings 638,128.24 -4.84 Mn - -5.57
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.57
Mar 31, 2026 -29.14
Dec 31, 2024 -42.91
Sep 30, 2024 -996.43
Jun 30, 2024 -303.25
Mar 31, 2024 -51.38
Dec 31, 2023 -55.81
Sep 30, 2023 -9,780.71
Jun 30, 2023 -40.62
Mar 31, 2023 -152,396.63
API Access

Cero Therapeutics Holdings Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CERO&period=max&api_key=YOUR_API_KEY